Three-year experience with GLP-2 analog in intestinal rehabilitation for pediatric-onset short bowel syndrome
GLP-2 analog therapy, which is based on intestinal rehabilitation, contributed to a sustained reduction in PN and enhanced clinical outcomes over three years, particularly in adult SBS patients. Continuous GLP-2 analog therapy might improve quality of life in paediatric-onset SBS.
Authors
- Kōichi Deguchi (ORCID: https://orcid.org/0000-0001-6743-0185)
- Hiroomi Okuyama (ORCID: https://orcid.org/0000-0002-1347-282X)
- Naoko Uga
- Takehisa Ueno
- Yuko Tazuke (ORCID: https://orcid.org/0000-0002-8335-0414)
- Takaharu Oue (ORCID: https://orcid.org/0000-0002-9574-1826)
- Kengo Nakahata
- Takeshi Kimura (ORCID: https://orcid.org/0000-0002-5665-4076)
Institutions
- Osaka Gakuin University (JP)
- Hyogo Medical University (JP)
- Hyogo University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Pediatric Surgery International
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1007/s00383-025-06154-z
- Primary Topic
- Clinical Nutrition and Gastroenterology
- Type
- article
- Field-Weighted Citation Impact
- 0.00